Biology Reference
In-Depth Information
CHAPTER FIVE
Chemotherapeutic Strategies
for Reducing Transmission of
Plasmodium vivax Malaria
Nicholas M. Douglas * , , , 1 , George K. John * , Lorenz von Seidlein ,
Nicholas M. Anstey , , Ric N. Price * , ,
*Centre for Tropical Medicine, Nuffield Department of Clinical Medicine, University of Oxford,
Oxford, UK
Global Health Division, Menzies School of Health Research and Charles Darwin University,
Darwin, Australia
Department of Infectious Diseases, Division of Medicine, Royal Darwin Hospital, Darwin, Australia
1 Corresponding author: Email: nicholas.douglas@gmail.com
Contents
1. Introduction
272
2. Transmissionof P. vivax
273
3. Reducing P. vivax TransmissionbyTreatingSymptomaticDisease
278
3.1. EradicatingBlood-StageParasites
279
3.2. Post-treatmentProphylaxis
281
3.3. EradicatingHypnozoites
282
4. Reducing P. vivax TransmissionUsingMassDrugAdministration
286
5. Conclusions
291
Abstract
Effective use of anti-malarial drugs is key to reducing the transmission potential of
Plasmodium vivax . In patients presenting with symptomatic disease, treatment with
potent and relatively slowly eliminated blood schizontocidal regimens administered
concurrently with a supervised course of 7  mg/kg primaquine over 7-14  days has
potential to exert the greatest transmission-blocking benefit. Given the spread of
chloroquine-resistant P. vivax strains,theartemisinincombinationtherapiesdihydroar-
temisinin + piperaquineandartesunate + mefloquinearecurrentlythemostassured
means of preventing P. vivax recrudescence. Preliminary evidence suggests that, like
chloroquine,thesecombinationspotentiatethehypnozoitocidaleffectofprimaquine,
butfurthersupportiveevidenceisrequired.Inviewofthehighrateof P. vivax relapse
followingfalciparuminfectionsinco-endemicregions,thereisastrongargumentfor
broadeningcurrentradicalcurepolicytoincludetheadministrationofhypnozoitocidal
dosesofprimaquinetopatientswith Plasmodium falciparum malaria.Themostimpor-
tant reservoir for P. vivax transmission is likely to be very low-density, asymptomatic
Search WWH ::




Custom Search